Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

12 Feb 2018

Abstract excerpt

The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence based on expression of 31 genes. The current study was designed to assess the analytical validity of this test. Inter-assay,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous Melanoma Detection and Management
Share to Melanoma and MAPK Pathways
Share to Nonmelanoma Skin Cancer Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29433548
DOI: 10.1186/s13000-018-0690-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patientsPMID 29433548Read ↗

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patientsSemantic proximity Read ↗

Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile testSemantic proximity Read ↗

Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) PatientsSemantic proximity Read ↗

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanomaSemantic proximity Read ↗

Prognostic and predictive biomarkers in melanoma: an updateSemantic proximity Read ↗

Guidance of Sentinel Lymph Node Biopsy Decisions In Patients With T1–T2 Melanoma Using Gene Expression ProfilingSemantic proximity Read ↗

Gene Expression Profiling for the Diagnosis of Multiple Primary Malignant TumorsSemantic proximity Read ↗

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanomaSemantic proximity Read ↗

Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.Semantic proximity Read ↗

The Role of Gene Expression Profiling in Management of Cutaneous Squamous Cell Cancer: A ReviewSemantic proximity Read ↗

Translation of a circulating microRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.Semantic proximity Read ↗

Gene expression profiling for the diagnosis of multiple primary malignant tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.